Impact of initial treatment outcome on long-term costs of depression: A 3-year nationwide follow-up study in Taiwan

Psychological Medicine

Volumn 44, Issue 6, 2014, Pages 1147-1158

  Pan, Y J ^a,b,c   Knapp, M ^a,d   McCrone, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Cost; depression; longitudinal study; treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; DEPRESSIVE DISORDER; ECONOMICS; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MALE; STATISTICS AND NUMERICAL DATA; TAIWAN; TIME; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; MALE; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84926075117     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713001700     Document Type: Article

References (28)

1. Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FR (2005). The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. International Journal of Geriatric Psychiatry 20, 523-530.
2. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, VolleberghWA (2004). Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica. Supplementum 420, 47-54.
3. Bergh S, Engedal K, Roen I, Selbaek G (2011). The course of neuropsychiatric symptoms in patients with dementia in Norwegian nursing homes. International Psychogeriatrics 23, 1231-1239.
4. Byford S, Barrett B, Despiegel N, Wade A (2011). Impact of treatment success on health service use and cost in depression: longitudinal database analysis. Pharmacoeconomics 29, 157-170.
5. Chen L, Yip W, Chang MC, Lin HS, Lee SD, Chiu YL, Lin YH (2007). The effects of Taiwan's national health insurance on access and health status of the elderly. Health Economics 16, 223-242.
6. Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM (2004). The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? Journal of Clinical Psychiatry 65, 521-530.
7. Gameroff MJ, Olfson M (2006). Major depressive disorder, somatic pain, and health care costs in an urban primary care practice. Journal of Clinical Psychiatry 67, 1232-1239.
8. IMF (2013). EconStats. Implied PPP conversion rate. World Economic Outlook (WEO) data (www.econstats.com/weo/ V013.htm). Accessed 5 April 2013.
9. Katon WJ (2003). Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry 54, 216-226.
10. Keller MB, Shapiro RW (1981). Major depressive disorder. Initial results from a one-year prospective naturalistic follow-up study. Journal of Nervous and Mental Disease 169, 761-768.
11. Lin EH, Katon WJ, Von Korff M, Russo JE, Simon GE, Bush TM, Rutter CM, Walker EA, Ludman E (1998). Relapse of depression in primary care. Rate and clinical predictors. Archives of Family Medicine 7, 443-449.
12. McCullagh P, Nelder J (1989). Generalized Linear Models. Chapman and Hall: London.
13. Mojtabai R, Olfson M, Mechanic D (2002). Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Archives of General Psychiatry 59, 77-84.
14. Pan YJ, Knapp M, McCrone P (2012). Cost-effectiveness comparisons between antidepressant treatments in depression: evidence from database analyses and prospective studies. Journal of Affective Disorders 139, 113-125.
15. Pan YJ, Knapp M, Yeh LL, Chen YP, McCrone P (2013a). Treatment costs for depression with pain and cardiovascular comorbidities. Journal of Psychiatric Research 47, 329-336.
16. Pan YJ, Liu SK, Yeh LL (2013b). Factors affecting early attrition and later treatment course of antidepressant treatment of depression in naturalistic settings: an 18-month nationwide population-based study. Journal of Psychiatric Research 47, 916-925.
17. Paykel ES (1998). Remission and residual symptomatology in major depression. Psychopathology 31, 5-14.
18. Rush AJ, Wisniewski SR, Zisook S, Fava M, Sung SC, Haley CL, Chan HN, Gilmer WS, Warden D, Nierenberg AA, Balasubramani GK, Gaynes BN, Trivedi MH, Hollon SD (2012). Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR∗D report. Psychological Medicine 42, 1131-1149.
19. Savva GM, Zaccai J, Matthews FE, Davidson JE, McKeith I, Brayne C (2009). Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. British Journal of Psychiatry 194, 212-219.
20. Shapiro RW, Keller MB (1981). Initial 6-month follow-up of patients with major depressive disorder. a preliminary report from the NIMH collaborative study of the psychobiology of depression. Journal of Affective Disorders 3, 205-220.
21. Sicras-Mainar A, Blanca-Tamayo M, Gutierrez-Nicuesa L, Salvatella-Pasant J, Navarro-Artieda R (2010a). Impact of morbidity, resource use and costs on maintenance of remission of major depression in Spain: a longitudinal study in a population setting. Gaceta Sanitaria 24, 13-19.
22. Sicras-Mainar A, Blanca-Tamayo M, Gutierrez-Nicuesa L, Salvatella-Pasant J, Navarro-Artieda R (2010b). Clinical validity of a population database definition of remission in patients with major depression. BMC Public Health 10, 64.
23. Simon GE, Khandker RK, Ichikawa L, Operskalski BH (2006). Recovery from depression predicts lower health services costs. Journal of Clinical Psychiatry 67, 1226-1231.
24. Simon GE, VonKorff M, Barlow W (1995). Health care costs of primary care patients with recognized depression. Archives of General Psychiatry 52, 850-856.
25. Sobocki P, Ekman M, Agren H, Runeson B, Jonsson B (2006). The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression. International Journal of Clinical Practice 60, 791-798.
26. van der Lem R, van der Wee NJ, van Veen T, Zitman FG (2011). The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychological Medicine 41, 1353-1363.
27. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163-2196.
28. Wetzels RB, Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT (2010). Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. American Journal of Geriatric Psychiatry 18, 1054-1065.